SOURCE: Pharmacure

Pharmacure

August 01, 2016 16:19 ET

Pharmacure Attends ECRM and Makes Big Splash

Retailers Showed Serious Interest in the Brand

BOCA RATON, FL--(Marketwired - August 01, 2016) - Pharmacure, a company that develops a line of cosmetics and medical devices to promote better nasal health and comfort, announced the company was successful in forging some important new connections for its Nozohaem product when it attended the 2016 ECRM Diet, Vitamin & Sports Nutrition conference in Tampa, Florida.

This specific ECRM event gives companies in the nutritional, sports and health fields a chance to gather together and meet with some of the most influential retail buyers in their respective industries. Sales executives report outstanding performance at the event, and are very positive about their future coming out of it.

"We had the opportunity to meet with some of the industry's heavy hitters in Walgreens, Vitamin Shoppe, Smith Drug, Vitamin World, CVS, Cardinal Health, Jet.com and AmeriMark," said Helena Törnell of Pharmacure. "These connections will mean possible new business and sales opportunities for Pharmacure."

Pharmacure, a company that develops a line of cosmetics and medical devices to promote better nasal health and comfort, announced its product, Nozohaem, has been successful in the US Market and the company is looking to expand its reach.

Nozohaem is an easy and unique treatment option for nosebleeds that stops the bleeding just moments after its application. The easy-to-use gel is completely safe and can be applied in seconds. Now that it is available on Amazon.com, the product will be available to a broader base of customers than ever before.

Nozohaem has no side effects, meaning anyone who has a nosebleed can use it without having to worry about any medical risks. However, children below the age of seven should have a parent apply the gel for them. Before application, blow your nose to remove any blood inside, then insert the tube approximately a centimeter into the nostril and press the gel out of the tube slowly. A single tube should be sufficient for an application. Continue to apply until bleeding stops. Gel should remain inside the nose leaving the vessel to heal. Nozohaem is slowly being transported away by the ciliar, so there is no need to blow it out.

"It was extremely important to be involved in the ECRM trade show, and we're very excited about the possible opportunities we have in store from it," said Helena Törnell. "We can't wait to further our product availability in the US Market."

For more information about Pharmacure and its products, visit www.pharmacure.com.

Contact Information